Wrinkles

... The Miracle of Botox - Effect on Wrinkles (Part 2) A {text-decoration: none;} Home Top Stories Sports Entertainment Health News Business Personal Finance Real Estate Business Finance Insurance Consulting Tax News Forum Writers Featured Articles Search: The Miracle of Botox - Effect on Wrinkles (Part 2) February 2nd 2006 Botox Wrinkle Treatment Which wrinkles and lines bother you the most?

Are these lines and wrinkles the type that are best eliminated using Botox?

If you choose to eliminate only the wrinkles that can be treated with Botox, will any of the remaining ones still leave you unsatisfied with your appearance?

For example, if you want both your frown lines and marionette lines removed, you will likely need a different cosmetic procedure to have the marionette lines eliminated.

It should point out that Botox injections work best on crow's-feet (wrinkles radiating from the outside corners of the eyes), worry lines (horizontal forehead lines), and frown lines (vertical lines, also called glabellar lines, that appear be­tween the eyebrows).

These are wrinkles that are typically caused by chronic contractions of the muscles under or adja­cent to these areas of the face.

Laughing, smiling, frowning, and squinting are some of the common facial expressions that can cause these lines.

If you have lines and wrinkles on other parts of your face that concern you, you may need other types of cosmetic procedures to eliminat...

... Allergan 4Q Earnings Climb 8 Percent Allergan 4Q Earnings Climb 8 Percent Staff and agencies02 February, 2006 By ALEX VEIGA, AP Business Writer 30 minutes ago LOS ANGELES - Allergan Inc., best known for the Botox wrinkle treatment, said Thursday its fourth-quarter profit increased 8 percent on the strength of higher pharmaceutical sales.

Revenue rose 7 percent to $594.9 million from $556.2 million in 2004, with pharmaceuticals sales up 11 percent.

Eye-care sales rose 13 percent to $340.6 million from a year ago.

"It appears to be another high-quality quarter from Allergan, but one marked by one of the slowest growth in eye care pharmaceuticals in two years and the slowest growth in Botox ever," wrote Bank of America analyst David W.

Maris in a note Thursday.

Investors seemed to also take note of the lighter Botox and eye care product sales, driving shares of Allergan down $2.38, or 2.1 percent, to $112.48 in afternoon trading on the New York Stock Exchange New York Stock Exchange.

Pyott also said he expects the Federal Trade Commission will clear Allergan‘s acquisition of Santa Barbara-based Inamed Corp.

within a few weeks.

Allergan made a $3.2 billion cash-and-stock offer for Inamed in November.

Inamed makes a range of "dermal filler" products used to smooth wrinkles that Allergan sees as a complement to its market-leading Botox antiwrinkle treatment.

Pyott said the company is seeking approval for Botox as a treatment for overactive bladders and hea...

... Allergan Fourth-Quarter Earnings Jump 8 Percent to $122 Million on Higher Pharmaceutical Sales Canadian Business Online My CB e-Newsletters My Portfolio RSS Advisory Panel Stocks Bonds Commodities Headline News Market News Earnings News M&As & IPOs Career Employees Strategy B School Live and Learn My Tech Companies Trends Lists My Watchlist My Portfolio Gotta have it Gotta do it Think About This AB BC MB NB AB NL NS NT NU ON PE QC SK YT AB BC MB NB AB NL NS NT NU ON PE QC SK YT #breadcrumbs, #breadcrumbs a {text-transform:uppercase !

important;} Markets Home Stocks Bonds/Fixed Income Commodities Income Trusts Headline News Market News Earnings News M&As and IPOs Ga...